Figure 2

The genomic imbalances detected by HR-CGH in 11 borderline ovarian tumors. Gains are shown in green and losses in red color.
The genomic imbalances detected by HR-CGH in 11 borderline ovarian tumors. Gains are shown in green and losses in red color.